Connect with us

Global Market

Global Neurotrophic Keratitis Market is anticipated to expand at a CAGR of 5.1% from 2019 to 2027

Published

on

Press Release

The major symptoms associated with neurotrophic keratitis are red & dry eyes, blurred vision, pain, and discomfort in the eye. Approval of promising drugs such as Oxervate and TB4 is going to completely revolutionize the treatment regimen for neurotrophic keratitis during the forecast period.

National Organization for Rare Disease has designated neurotrophic keratitis is a rare disease highlighting a prevalence rate of 5 per 10,000 people. The major causative agent is the herpes zoster virus and herpes simplex virus. The clinical manifestation of the disease is the progressive damage of nerve innervations of the trigeminal nucleus present in the corneal region of the eye. It results in obliteration of the healing process of the corneal surface. Ophthalmologists across the globe are adopting a treatment regimen on the basis of the different stages of the disease. Preservative-free artificial tears are dominating the medication segment owing to its capability to provide lubrication and moisture, it initiates lacrimation to ensure eye hygiene. Regenerative human nerve growth factors will be influencing the market during the forecast period owing to its effective therapeutic index against neurotrophic keratitis infection. The surgical intervention segment is further classified as tarsorrhaphy and amniotic membrane transplantation, they are proven beneficial during the 3rd stage of the infection for the treatment of corneal ulcer.

Browse the full report Neurotrophic Keratitis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/neurotrophic-keratitis-market

North America is presently is spearheading the geography segment in the neurotrophic keratitis market. According to the vital statistics provided by the National Institute of Health (NIH) research for ophthalmology disorders, the prevalence rate of the population undergoing surgical intervention for neurotrophic keratitis is 1.5 per 10,000 population. Furthermore, herpes zoster has been identified as the major causative agent to initiate the prognosis of neurotrophic keratitis in the North American region. Chief contributing factors such as high incidence rate and affordable reimbursement scenario accentuates the growth of neurotrophic keratitis in the region. Europe is the 2nd largest regional market for neurotrophic keratitis treatment owing to proactive role adopted by European Medical Agency (EMA) to expedite the drug development protocols pertaining to neurotrophic keratitis Effective research partnership between biopharmaceutical companies and academic research institutes specializing in eye care further support the market growth in Europe region. The Asia Pacific is showcasing promising growth in the near future on account of the rising prevalence of neurotrophic keratitis in the elderly population and developing healthcare infrastructure relevant to ophthalmology research and care centers.

Biopharmaceutical companies pioneering in the treatment of neurotrophic keratitis are Allergan, Plc., Dompe farmaceutici S.p.A., Abbott Laboratories, Inc., CooperVision, Neuroptika, Bausch & Lomb Incorporated, ReGenTree, LLC., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Novartis AG.

Market Key Takeaways:

  • The exponential rise in the incidence rate of neurotrophic keratitis throughout the globe
  • Affordable reimbursement scenario for the medications employed in the treatment for 1st and 2nd stage neurotrophic keratitis
  • USFDA has awarded priority review designation to facilitate the market growth of Oxervate in developed regions such as as Europe and North America

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Lidocaine Transdermal Patch Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

Published

on

Press Release

Lidocaine is categorized as a local anesthetic which acts by blocking the voltage-gated sodium channel in the central nervous system. The rising prevalence of neuropathic pain and technological advancement in the transdermal drug delivery system will together drive the market growth.

Post-herpetic neuralgia is dominating the clinical application segment in the lidocaine transdermal patch market. The growing incidence of Herpes zoster viral infection due to unsafe sex practices is responsible for the disease etiology of post-herpetic neuralgia. It is also known as shingles infection, which recurs due to reactivation of the varicella-zoster viral infection. The early symptoms associate with the shingles infection is the development of cold sores in the genitalia region which is severely painful, burning sensation, and highly sensitive to touch. The joint pain will be projecting exemplary market growth on account of the growing popularity of sports and athletic activities often resulting in acute joint injuries. Additionally, increasing the geriatric population suffering from osteoporosis causing arthritis will further accentuate the market growth.

Browse the full report Lidocaine Transdermal Patch Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/lidocaine-transdermal-patch-market

Hospital pharmacy is currently ruling the distribution channel segment in the lidocaine transdermal patch market. The rising prevalence of osteoarthritis causing severe joint pains determines the market growth. Different strengths of lidocaine transdermal patch are dispensed by hospital pharmacists according to the degree of pain intensity and kind of joint pain. Retail pharmacies are garnering huge popularity as a sales channel among consumers worldwide. Flourishing generic medicines market in the developing regions further propel its market growth.

North America is currently leading the geography segment for the lidocaine transdermal patch market. The growing incidence of osteoporosis in the geriatric population causing throbbing joint pain primarily drives the market growth in the region. According to the latest information provided by the Center for Disease Control and Prevention (CDC), approximately 20.4 % population in the United States are suffering from chronic joint pain. Additionally, rising public health awareness pertaining to neuropathic pain and its treatment drives the lidocaine transdermal patch market growth in the region. Europe is placed 2nd in the regional segment due to the significant increase in the number of adults suffering from a shingles infection. As per the statistics provided by the European Commission report, the prevalence rate associated with Herpes Zoster in Europe is 2.5 per 1000 people. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The constant rise in the injuries associated with sports and athletic activities and flourishing over the counter analgesics market together with determining the lidocaine transdermal patch market in the region.

Pharmaceutical manufacturers actively engaged in the production of Lidocaine Transdermal Patch are Endo International, Plc., Mylan N.V., Teva Pharmaceutical Industries, Ltd., Hisamitsu Pharmaceuticals Co., Inc., Sorrento Therapeutics, Inc., Galen Limited, Seqirus Pty Ltd., ACTAVIS LABS UT INC, CERAMISPHERE and Aetna, Inc.

Key Market Movements:

  • Rising prevalence of shingles infection among the adult population worldwide
  • Significant increase in the number of musculoskeletal disorders causing throbbing joint pains will further accentuate the market growth
  • Technological advancement in the transdermal drug delivery system to provide local anesthetic effect will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Electrosurgical Cutting Forceps Market is expected to grow at a CAGR of 6.0% from 2020 to 2027

Published

on

Press Release

The primary purpose of electrosurgical devices is caused to prevent the bleeding by causing the coagulation of tissue at the site of surgery with the help of either Monopolar or bipolar forceps. Technological advancement in the electrochemical devices and increasing demand for minimally invasive surgical procedures drive the electrosurgical cutting forceps market growth.

In the present situation, the Monopolar forceps are dominating the types segment for the electrosurgical cutting forceps market. The major factors contributing to its market dominance are its applicability in surgical procedures requiring a high degree of tissue desiccation, vaporization and coagulation, and fulguration. Bipolar forceps have gained tremendous demand in the last decade owing to its ability to perform laparoscopic surgical procedures worldwide. Furthermore the ability to coagulate tissue in a fluid environment, and the flow of current being limited to the surgical site ultimately results in the prevention of tissue burns and damages.

Browse the full report Electrosurgical Cutting Forceps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 report at https://www.atlanticmarketresearch.com/electrosurgical-cutting-forceps-market

Hospitals and clinics are currently representing the largest end-user market for the electrosurgical cutting forceps. Significant rise in the number of outpatient admissions to undergo the surgical procedure as the only viable treatment option for chronic diseases. Huge funding by healthcare agencies worldwide to provide technological advanced electrosurgical devices to hospitals and clinics worldwide. Ambulatory surgical centers are gaining huge traction owing to its ability to drastically reduce the healthcare cost burden of ailing patients and a significant rise in the number of inpatient population opting minimally invasive surgical procedures throughout the globe.

North America is presently spearheading the geography segment for the electrosurgical cutting forceps market. As per the research findings brought forward by the U.S. Department for Health & Human Services in 2018, approximately 129 million outpatient surgeries were performed in the United States. The chief contributing factors such as increasing demand for non-invasive surgical procedures and the presence of key players such as Aesculap, Inc., Elite Medical, CONMED Corporation, Stryker, etc. further promote a positive impetus to the electrosurgical cutting forceps market growth in the region. In Europe, the market growth is defined by the proactive role adopted by the European Medical Agency (EMA) for the early clearance of electrosurgical devices. Western Europe has been pioneering in the manufacturing of invasive and noninvasive surgical devices for centuries and is anticipated to continue the trend during the forecast period. The Asia Pacific is expected to register comfortable growth in the near future owing to the significant rise in medical tourism. The constant rise in the ambulatory surgical centers to address emergency situations in the remote areas further propels the market growth in the region.

Medical device manufacturers engaged in the production of electrosurgical devices are Aesculap, Inc., Erbe Elektromedizin GmbH, Elite Medical, Medtronic, Plc., Ethicon, Inc., Bovie Medical, CONMED Corporation, Bissinger Medizintechnik GmbH, Stryker and BOWA-electronic GmbH & Co. KG.

Market key Takeaways:

  • Significant increase in the number of surgical procedures performed as the only treatment option for chronic diseases
  • Technological advancement in the development of Monopolar and bipolar forceps minimizing tissue burns and damages
  • Increasing demand for minimally invasive surgical procedures and constant rise in the ambulatory surgical centers together drive the electrosurgical cutting forceps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Mothballs Market is expected to grow at a CAGR of 5.4% from 2020 to 2027

Published

on

Press Release

Mothballs produce fumes which curb the manifestation of moths, larvae, and eggs. The synthetic mothballs produce toxic fumes as they are sublime in nature and can prove toxic on exposure to children. Naphthalene mothballs and 1,4 paradichlorobenzene have potent carcinogenic properties and hence there is been an increasing demand for nontoxic natural mothballs which is moth repellant and deodorant.

The synthetic mothballs are holding the largest market in the type segment for the mothballs market. Chemical moieties such as naphthalene and 1,4 dichlorobenzene are used in manufacturing synthetic mothballs owing to its excellent physicochemical properties such as heat resistance and sublime nature that produces toxic vapors which curbs the manifestation of moths, larvae and eggs in closet, house pantry and toilets. Natural mothballs are manufactured using chemical moieties such as cedarwood oil, camphor oil, and lavender oil, which has potent moth repellent properties and produces good fragrance in closed indoor areas.

Browse the full report Mothballs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/mothballs-market

Household demand for mothballs is on a constant rise as the heated house ventilation in cold winters promotes the manifestation of moths. The huge destruction caused to costly textiles, fabrics, cereals, and grains further fortify the household demand for mothballs. The commercial demand for mothballs is increasing due to a concomitant rise in the pest management industry. The availability of mothballs as flakes, marbles, blocks, and cases provides excellent deodorization and sanitation in huge commercial spaces and retail outlets.

North America is considered the largest market for mothballs on account of the climatic conditions which produces excellent breeding grounds for gypsy moths which causes huge destruction of wooden furniture made from hardwood and conifer. Mothballs containing pheromones are currently being used in the Eastern coast of the United States to prevent the spread of gypsy moths westwards. The presence of key players such as Enoz, Boxania, Hovex, Merck Millipore, etc. further provides a positive stimulus to the mothball market growth in the region. In Europe the heated house ventilation during the cold winters provides beneficial breeding grounds for cloth moth and pantry moth which causes destruction of costly textiles, fabrics, cereals, and grains. Chemical companies and academic research institutes are collaborating for the development of natural mothballs and pheromones to curb the manifestation of moths, larvae, and eggs in closed indoor areas in the Eastern Europe region. It is expected that the Asia Pacific will register positive market growth in the forecast period on account of unhygienic sanitary conditions in the house pantry and the emergence of local players pioneering in the production of synthetic mothballs.

Chemical companies engaged in the production of mothballs are Enoz, Boxania, Hovex, Henkel Ltd., Wego Chemical Group, Merck Millipore, Sigma Aldrich, Pan Chem Corporation, Roeper GmbH, and Hangerworld Ltd.

Market Key Takeaways:

  • Constant rise in the manifestation of clothing moth and pantry moth due to heated house ventilation in cold winters
  • Increasing demand for natural mothballs owing to its non-toxic nature and availability in attractive fragrances
  • Mothballs are being developed by addition of pheromones to trap moths in closed indoor areas

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Trending

Copyright © 2019 Melanian News